New Zealand markets closed

Aurobindo Pharma Limited (AUROPHARMA.NS)

NSE - NSE Real-time price. Currency in INR
Add to watchlist
1,239.20+26.15 (+2.16%)
As of 01:43PM IST. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/03/2024
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Assets
Current assets
Cash
Cash and cash equivalents
33,934,800
43,962,900
41,625,100
53,734,700
-
Other short-term investments
31,985,100
18,273,400
3,951,300
2,477,300
-
Total cash
65,919,900
62,236,300
45,576,400
56,212,000
-
Net receivables
48,167,400
44,663,800
40,122,600
35,032,800
-
Inventory
98,082,300
85,112,300
75,538,500
90,265,700
-
Other current assets
25,364,300
18,687,000
15,550,100
14,488,100
-
Total current assets
242,056,300
215,456,700
181,226,900
198,235,100
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
142,849,000
180,511,300
145,340,200
93,155,100
-
Accumulated depreciation
-
-55,593,500
-38,680,300
-31,457,100
-24,827,100
Net property, plant and equipment
142,849,000
124,917,800
106,659,900
93,155,100
-
Goodwill
5,951,500
5,960,700
4,754,200
4,289,000
-
Intangible assets
34,814,600
33,258,500
31,378,700
26,907,000
-
Other long-term assets
2,299,600
45,300
100
4,326,500
-
Total non-current assets
208,658,800
183,443,200
157,990,300
140,304,800
-
Total assets
450,715,100
398,899,900
339,217,200
338,539,900
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
41,803,200
42,425,600
25,512,500
48,037,800
-
Accounts payable
44,541,600
38,713,100
27,030,500
27,946,800
-
Other current liabilities
8,773,800
2,235,900
1,279,400
5,561,900
-
Total current liabilities
121,991,300
114,937,800
81,559,800
106,650,500
-
Non-current liabilities
Long-term debt
21,349,000
6,189,600
2,492,100
1,684,900
-
Deferred tax liabilities
3,565,600
3,896,100
4,109,600
5,745,600
-
Other long-term liabilities
364,700
-15,153,200
297,700
395,000
-
Total non-current liabilities
30,215,800
15,443,600
11,916,900
12,599,500
-
Total liabilities
152,207,100
130,381,400
93,476,700
119,250,000
-
Stockholders' equity
Common stock
585,900
585,900
585,900
585,900
-
Retained earnings
-
240,130,300
225,190,100
201,367,600
150,424,000
Total stockholders' equity
298,428,000
268,398,500
245,759,800
219,298,700
-
Total liabilities and stockholders' equity
450,715,100
398,899,900
339,217,200
338,539,900
-